Total Payments
$2,429
2024 Payments
$57.53
Companies
19
Transactions
110
Medicare Patients
5,009
Medicare Billing
$600,099
Payment Breakdown by Category
Food & Beverage$2,231 (91.8%)
Education$198.00 (8.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,231 | 108 | 91.8% |
| Education | $198.00 | 2 | 8.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $364.80 | 23 | $0 (2023) |
| Abbott Laboratories | $295.53 | 5 | $0 (2023) |
| Merck Sharp & Dohme LLC | $292.22 | 19 | $0 (2023) |
| Astellas Pharma US Inc | $261.33 | 6 | $0 (2020) |
| Medtronic Vascular, Inc. | $205.54 | 4 | $0 (2020) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $157.89 | 10 | $0 (2022) |
| PFIZER INC. | $154.73 | 7 | $0 (2022) |
| Amgen Inc. | $134.26 | 7 | $0 (2020) |
| Medtronic, Inc. | $134.14 | 5 | $0 (2022) |
| Actelion Pharmaceuticals US, Inc. | $127.40 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $57.53 | 2 | Vital Connect, Inc ($57.53) |
| 2023 | $184.41 | 7 | Abbott Laboratories ($78.70) |
| 2022 | $583.74 | 33 | Merck Sharp & Dohme LLC ($141.12) |
| 2021 | $508.63 | 27 | PFIZER INC. ($124.14) |
| 2020 | $352.87 | 16 | Amgen Inc. ($96.32) |
| 2019 | $369.64 | 13 | Astellas Pharma US Inc ($245.87) |
| 2018 | $319.56 | 8 | Abbott Laboratories ($155.51) |
| 2017 | $52.54 | 4 | BOSTON SCIENTIFIC CORPORATION ($23.47) |
All Payment Transactions
110 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Vital Connect, Inc | VITALPATCH RTM (Device) | Food and Beverage | In-kind items and services | $40.13 | General |
| Category: CARDIOLOGY | ||||||
| 09/03/2024 | Vital Connect, Inc | VITALPATCH RTM (Device) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: CARDIOLOGY | ||||||
| 07/27/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/20/2023 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $78.70 | General |
| Category: Cardiac Rhythm Management | ||||||
| 03/02/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/15/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/09/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/02/2023 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Genetic Disease | ||||||
| 01/12/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/17/2022 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Transcatheter Valve Systems | ||||||
| 11/14/2022 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/11/2022 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $16.35 | General |
| Category: Cardiology | ||||||
| 11/03/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/27/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.65 | General |
| Category: Cardiovascular | ||||||
| 10/20/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/06/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/29/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/28/2022 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $30.45 | General |
| Category: Cardiology | ||||||
| 09/22/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.90 | General |
| Category: Cardiovascular | ||||||
| 09/15/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/01/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/18/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.75 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/13/2022 | Boston Scientific Corporation | RESONATE EL ICD VR (Device) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: RESONATE_CRM | ||||||
| 08/11/2022 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Genetic Disease | ||||||
| 08/05/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 725 | 1,083 | $174,101 | $71,671 |
| 2022 | 21 | 1,522 | 2,429 | $382,499 | $153,964 |
| 2021 | 25 | 1,568 | 2,586 | $492,768 | $190,225 |
| 2020 | 19 | 1,194 | 1,961 | $403,282 | $184,239 |
Total Patients
5,009
Total Services
8,059
Medicare Billing
$600,099
Procedure Codes
85
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 81 | 226 | $43,842 | $21,313 | 48.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 111 | 271 | $35,285 | $15,979 | 45.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 85 | 91 | $25,496 | $12,250 | 48.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 110 | 113 | $27,000 | $5,463 | 20.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 55 | 59 | $11,800 | $5,445 | 46.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 35 | $6,005 | $3,186 | 53.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 51 | $5,960 | $2,942 | 49.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 36 | 53 | $4,770 | $1,899 | 39.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 38 | 38 | $2,470 | $1,377 | 55.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 12 | 12 | $1,560 | $655.88 | 42.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 48 | 63 | $1,890 | $412.06 | 21.8% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 14 | 16 | $3,600 | $304.32 | 8.5% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 19 | 22 | $2,110 | $215.69 | 10.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 20 | 20 | $688.00 | $198.94 | 28.9% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 13 | 13 | $1,625 | $30.42 | 1.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 266 | 899 | $116,870 | $50,260 | 43.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 182 | 203 | $40,600 | $21,463 | 52.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 317 | 333 | $69,680 | $18,203 | 26.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 75 | 79 | $23,700 | $12,124 | 51.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 59 | 122 | $25,620 | $9,737 | 38.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 103 | 132 | $14,520 | $7,931 | 54.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 78 | $12,480 | $6,682 | 53.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 97 | 189 | $17,010 | $5,740 | 33.7% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2022 | 11 | 12 | $13,200 | $5,635 | 42.7% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2022 | 24 | 24 | $12,000 | $4,050 | 33.8% |
About Dr. Ankush Moza, M.D
Dr. Ankush Moza, M.D is a Cardiovascular Disease healthcare provider based in Flint, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2009. The National Provider Identifier (NPI) number assigned to this provider is 1982834826.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ankush Moza, M.D has received a total of $2,429 in payments from pharmaceutical and medical device companies, with $57.53 received in 2024. These payments were reported across 110 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,231).
As a Medicare-enrolled provider, Moza has provided services to 5,009 Medicare beneficiaries, totaling 8,059 services with total Medicare billing of $600,099. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Flint, MI
- Active Since 07/24/2009
- Last Updated 01/17/2019
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1982834826
Products in Payments
- ENTRESTO (Drug) $364.80
- VERQUVO (Drug) $292.22
- LifeVest (Device) $157.89
- AMPLATZER Occluders (Device) $155.51
- VYNDAQEL (Drug) $139.32
- Corlanor (Drug) $134.26
- COREVALVE EVOLUT R (Device) $111.63
- OPSUMIT (Drug) $96.95
- CoreValve Evolut (Device) $92.32
- Reveal LINQ (Device) $78.91
- AVEIR (Device) $78.70
- LEXISCAN (Drug) $63.33
- VITALPATCH RTM (Device) $57.53
- CAMZYOS (Drug) $34.55
- Micra (Device) $34.31
- UPTRAVI (Drug) $30.45
- ONPATTRO (Drug) $29.98
- Confirm Rx (Device) $24.47
- HeartMate 3 Left Ventricular Assist Device (Device) $23.92
- FARXIGA (Drug) $23.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Flint
Dr. Syed Ahmed, M.d, M.D
Cardiovascular Disease — Payments: $39,933
Cardiovascular Disease $39,933
Dr. Babikir Kheiri, Md, MD
Cardiovascular Disease — Payments: $21,912
Cardiovascular Disease $21,912
Dr. James Chambers, D.o, D.O
Cardiovascular Disease — Payments: $21,832
Cardiovascular Disease $21,832
Dr. George Predeteanu, M.d, M.D
Cardiovascular Disease — Payments: $15,230
Cardiovascular Disease $15,230
Dr. Abdul Hasnie, M.d, M.D
Cardiovascular Disease — Payments: $12,625
Cardiovascular Disease $12,625
Mr. Samir Elian, M.d, M.D
Cardiovascular Disease — Payments: $11,402
Cardiovascular Disease $11,402